A worldwide project explores the pediatric respiratory system
Participating DZL scientists receive €535,000 in funding from the Chan Zuckerberg Initiative.
Participating DZL scientists receive €535,000 in funding from the Chan Zuckerberg Initiative.
DZL scientists identified a new player within the pressure regulation in pulmonary vessels
Breath analysis by mass spectroscopic methods could enable innovative diagnostics.
DZL junior scientist investigates the development of pulmonary fibrosis at the cellular level.
Severe courses of infection with SARS-CoV-2 are characterized not only by strong immune activation and inflammatory reactions, but above all by dysfunction of the vascular system.
Project proposal in the key area of "Pathophysiology: Immunomodulation and Control" of the COFONI research network supported by the state of Lower Saxony is now successfully funded.
Further funding of clinical studies by the DZL in 2022. Two studies were successful in this year's application round.
Scientists at the DZL and Charité have found that a new triple therapy improves treatment outcomes for a common form of cystic fibrosis.
DZL scientists discover novel, attractive therapeutic strategy to treat PH with an active ingredient from the walnut.
An international research team, along with scientists from the DZL and the German Consortium for Translational Cancer Research (DKTK), has discovered a potential treatment approach for the lung disease COPD.
Allergy or no allergy? New basophil activation test complements spectrum of routine diagnostics.
Together with researchers from ILBD/CPC Helmholtz Zentrum München, DZL scientists have identified compounds that enable the development drugs against fibrosis.
